The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: Specifications for classification of variants in ADA , DCLRE1C , IL2RG , IL7R , JAK3 , RAG1 , and RAG2
Preprint
Abstract
Purpose: This collaborative study, led by the Clinical Genome Resource Severe Combined Immunodeficiency Disease Variant Curation Expert Panel (ClinGen SCID-VCEP), implemented and adapted the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) guidelines for interpreting germline variants in genes with established relationships to SCID. The effort focused on the 7 most common SCID-related genes identified by SCID newborn screening in North America: ADA , DCLRE1C , IL2RG , IL7R , JAK3 , RAG1 , and RAG2 . Methods: The SCID-VCEP conducted a rigorous review of variants that involved database analyses, literature review, and expert feedback to derive gene-specific modifications to the ACMG/AMP guidelines. These specifications were validated using a pilot set of 90 variants. Results: Of these 90 variants, 25 were classified as pathogenic, 21 as likely pathogenic, 14 as variants of uncertain significance (VUS), 18 as likely benign, and 12 as benign. Seventeen variants with conflicting classifications in ClinVar were successfully resolved. The criteria included modifications to 20 of the 28 original ACMG/AMP criteria specific to SCID-related genes. Conclusion: The SCID-specific variant curation guidelines developed by the SCID-VCEP will enhance the precision of SCID genetic diagnosis and provide a robust framework for interpreting variants in SCID-related genes, contributing to appropriate treatment of SCID.Keywords
This publication has 22 references indexed in Scilit:
- The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 DefinitionsJournal of Allergy and Clinical Immunology, 2022
- The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of ImmunityJournal of Clinical Immunology, 2022
- The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)Journal of Allergy and Clinical Immunology, 2019
- Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing lossHuman Mutation, 2018
- Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterionHuman Mutation, 2018
- Primary Immune Deficiency Treatment Consortium (PIDTC) updateJournal of Allergy and Clinical Immunology, 2016
- Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United StatesJAMA, 2014
- Massively parallel sequencing reveals maternal somatic IL2RG mosaicism in an X-linked severe combined immunodeficiency familyJournal of Allergy and Clinical Immunology, 2013
- Development of population-based newborn screening for severe combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2005
- Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiencyHuman Mutation, 2001